Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance, PALM outcomes, and quality of life.
|Articles|September 1, 1996
The American Journal of Managed Care
- September 1996
- Volume 2
- Issue 8
Establishing the Basis for Successful Disease Management Contracting
Advertisement
Articles in this issue
about 30 years ago
Potential Cost-Effectiveness of Acute Stroke Treatmentabout 30 years ago
Potential for SSRIs as Monotherapy for Comorbid Psychiatric Disordersabout 30 years ago
Accreditation Standards in Managed Careabout 30 years ago
A Closer Look at CapitationAdvertisement
Related to this article
An international eDelphi panel of 62 dermatologists agreed on a 2-step algorithm for tapering psoriasis biologics.
Real-world data from CHEST 2026 show ETI improved lung function and BMI in children with CF aged 6 to 11, with the most gains in F508del homozygotes.
Birth centers are unavailable in 10 states, and 39% of birth center births are self-pay, as licensing and Medicaid pay limit access, a report finds.
ASPEN links green sputum to neutrophils and exacerbations; brensocatib (DPP1) lowers purulence, while meta-analysis supports fewer flare-ups in bronchiectasis.
Narcolepsy and idiopathic hypersomnia can go undiagnosed for years, and Epworth and RU-SATED screening help clinicians spot true sleepiness sooner.
At CHEST 2026, 3 speakers explained why respiratory medications stay expensive, assessed what recent federal, state, and industry fixes have achieved, and urged clinicians to use their voices on behalf of patients.
Experts at CHEST 2026 urge pulmonologists to keep lung cancer in mind for younger patients who never smoked, to order screening and biomarker testing themselves, and to advocate for patients' access to care.
Advertisement
Advertisement
Trending on AJMC
1
Patents, Rebates, and a Policy Patchwork Keep Inhalers Costly, Panelists Say
2
How Flatiron Health’s Network Chief Is Building the Future For (and With) Community Oncology Practices
3
FDA Approves Ryzumvi for Presbyopia, Expanding its Label
4
Administrative Burden Keeps Clinicians From Bedside: Amy Morris, MD
5